This is a competitive renewal application for a NRSA grant T32 HD4435 which was first funded in 6/01/2003. The goal of the Institutional NRSA at Johns Hopkins University is to train pediatric residents and fellows to become successful junior faculty whose primary) research interest is in the diagnosis, pathogenesis and treatment of genetic and acquired disorders in children. To date we have funded 13 trainees, (6 women and 7 men; two under represented minority trainees, and trainees in Pediatric Hematology/Oncology, Neurology, Cardiology, Gastroenterology, Nephrology, Neonatology and Adolescent Medicine. Five of our trainees have now completed their training and have joined our faculty. The program recruits and trains individuals to use the most modern techniques in genetics, genomics, molecular biology and the principles of clinical research to address, pathogenesis, diagnoses, and therapy for pediatric disease. In 2006 the Pediatric residency program was awarded continued accreditation by the Residency Review Committee for Pediatrics of the ACGME. The residency program continues to attract approximately 25 M.D. /PhD. candidates per year during the intern matching process and in the past 5 years 4 residents have completed the Integrated Research Pathway. Over the last 5 years over half of our residents have entered subspecialty training. 18% of the present residents, 18 % of the 15 subspecialty fellows and 8% of the full time faculty are members of underrepresented minorities. The Department of Pediatrics presently has 28 million dollars in NIH research dollars which does NOT include >15 million dollars presently funded in Pediatric Oncology, Pediatric Genetics, Pediatric Neurology and Pediatric Developmental Biology (all these divisions are located outside of the Department of Pediatrics). It is our goal to use the NRSA funds to continue to recruit a diverse group of residents and fellows who wish to become clinician scientists, to provide them mentorship from both basic science and clinical departments, to insure that they have access to formal training in all aspects of basic and clinical research, and to provide an academic environment which will insure that they will become independent, productive pediatric clinician scientists. We have in place a plan for tracking our trainees and measuring their success through publications, grant funding and future academic appointments. ? ? ?
Ronda, Jocelyn; Gaydos, Charlotte A; Perin, Jamie et al. (2018) Does the Sex Risk Quiz Predict Mycoplasma genitalium Infection in Urban Adolescents and Young Adult Women? Sex Transm Dis 45:728-734 |
Giwa, Adebola; Ahmed, Rizwan; Donner, Thomas et al. (2017) Editorial: Ying and Yang Members of the Tumor Necrosis Factor Superfamily: Friends or Foes in Immune-Mediated Diseases and Cancer. Front Immunol 8:1584 |
Weidner, Melissa; Mitchell, Sally; Schwarz, Kathleen (2017) Percutaneous Transhepatic Cholangioplasty to Treat Multiple Intrahepatic Biliary Strictures After Hepatoportoenterostomy. J Pediatr Gastroenterol Nutr 64:200-202 |
Das, Breanne B; Ronda, Jocelyn; Trent, Maria (2016) Pelvic inflammatory disease: improving awareness, prevention, and treatment. Infect Drug Resist 9:191-7 |
Ogholikhan, Sina; Schwarz, Kathleen B (2016) Hepatitis Vaccines. Vaccines (Basel) 4: |
Wick, Elizabeth C; Rabizadeh, Shervin; Albesiano, Emilia et al. (2014) Stat3 activation in murine colitis induced by enterotoxigenic Bacteroides fragilis. Inflamm Bowel Dis 20:821-34 |
Bradley, Gia M; Carson, Kathryn A; Leonard, Amanda R et al. (2012) Nutritional outcomes following gastrostomy in children with cystic fibrosis. Pediatr Pulmonol 47:743-8 |
Bradley, Gia M; Blackman, Scott M; Watson, Christopher P et al. (2012) Genetic modifiers of nutritional status in cystic fibrosis. Am J Clin Nutr 96:1299-308 |
Conklin, Laurie S; Cuffari, Carmen; Okazaki, Toshihiko et al. (2012) 6-Mercaptopurine transport in human lymphocytes: correlation with drug-induced cytotoxicity. J Dig Dis 13:82-93 |
Wu, Shaoguang; Rhee, Ki-Jong; Albesiano, Emilia et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15:1016-22 |
Showing the most recent 10 out of 13 publications